Life Sciences Tools and Services
Company Overview of Promega Corporation
Promega Corporation provides solutions and technical support services for the life sciences industry. It manufactures reagents and instrumentations; and offers products in the areas of genomics, protein analysis and expression, cellular analysis, drug discovery, and genetic identity. The company also provides DNA and RNA quantitation, DNA extraction, and sample ID and mixed sample detection products; and bio chemicals and laboratory ware, such as buffers and reagents, nucleic acids, and nucleic acids purification accessories. In addition, it offers products and services in the areas of biologics, cell health and metabolism, cell signaling, cloning and DNA markers, DNA and RNA purification, d...
2800 Woods Hollow Road
Madison, WI 53711
Founded in 1978
Key Executives for Promega Corporation
Co-Founder, Chairman and Chief Executive Officer
Chief Technical Officer and Vice President
Vice President of Global Sales
Compensation as of Fiscal Year 2015.
Promega Corporation Key Developments
Promega Corporation's Promega PowerPlex Fusion 6C System Receives Approval by the FBI
Oct 13 15
Promega Corporation announced that the Promega PowerPlex® Fusion 6C System was granted approval by the FBI for use in laboratories that generate DNA records for the National DNA Index System (NDIS). NDIS, a component of the FBI’s CODIS system, is the U.S. national database containing nearly twelve million offender profiles used by authorities to help solve criminal investigations nationwide. Launched in January 2015, the PowerPlex Fusion 6C System is a 27-locus multiplex that combines common and informative loci, including SE33, Penta D and Penta E, to overcome typical challenges faced by laboratories, such as sample inhibitors, low levels of input DNA and degradation. Unlike other multiplexes, the PowerPlex Fusion 6C System contains three Y-STR loci to improve mixture analysis that is commonly done with crime scene samples. Laboratories can streamline workflow and stretch their budget using the PowerPlex Fusion 6C System because the kit is capable of direct amplification with 12.5µl reactions from numerous sample types, including FTA® cards, nonFTA cards and commonly used swabs. The PowerPlex Fusion 6C System meets CODIS and European standards, allowing laboratories to achieve the most inter-database compatibility and high discrimination of any commercially available autosomal STR kit.
Promega Corporation Announces Launch of NanoBRET Protein Interaction Assays
May 5 15
Promega Corporation announced the launch of NanoBRET Protein Interaction Assays, which use a new Bioluminescence Resonance Energy Transfer (BRET) technology that enables scientists to quantitatively measure protein: protein interactions in live cells. Traditional methods for studying interactions between proteins are commonly performed in vitro using only protein fragments and do not provide data in the context of the cellular environment. With NanoBRET Protein Interaction Assays, researchers can study both induction and inhibition of protein interactions in real time using full-length proteins expressed at physiologically relevant levels. Conventional BRET measures the interaction of proteins using a bioluminescent donor fused to a protein of interest and a fluorescent acceptor fused to its binding partner; the donor does not excite the fluorophore using light, but transfers resonance energy through dipole-dipole coupling. The optimized NanoBRET Protein Interaction Assays use NanoLuc® Luciferase as the energy donor and HaloTag® protein as the energy acceptor. NanoBRET Technology has improved spectral overlap, increased signal, and lower background, providing researchers with a reproducible method for monitoring and screening protein interactions. In addition, the brighter light output from NanoLuc enables use of NanoBRET even at low expression levels, while still providing efficient energy transfer.
Promega Corporation Announces Launch of GloMax Explorer Multimode Detection System, a Flexible Multimode Reader for Luminescence, Fluorescence and Absorbance Detection
Apr 30 15
Promega Corporation announced the launch of GloMax Explorer Multimode Detection System, a flexible multimode reader for luminescence, fluorescence and absorbance detection integrated with over 50 optimized, preloaded Promega protocols to address a variety of research needs. The GloMax Explorer System is designed with preloaded Promega protocols to minimize time spent optimizing instrument settings. Complemented by the wide range of integrated Promega assays, including nucleic acid quantitation for next-generation sequencing, GloMax Explorer provides high sensitivity, a broad dynamic range and low well-to-well cross talk that generate more usable and relevant data. Users also have the option of customizing their own protocols in accordance with specific needs. As the newest member of the GloMax® System detection instruments, GloMax Explorer allows researchers to choose a range of detection modules for their current work and upgrade capabilities as their experimental needs grow. Multiplexed cell viability, apoptosis and cytotoxicity assays are easily performed with minimal manual intervention because of automated filter switching. The software is SiLA compatible, making integration of device control simple. Using the instrument’s touchscreen display and automatic gain adjustments, researchers can quickly generate and analyze data from critical experiments with minimal set-up time and effort. From the touchscreen, users can set up a plate map, view data in a heat map display and easily export their results to a variety of locations without complicated adjustments.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 5, 2015